Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-15-000032

CEO bought 35,000 shares at an average $0.17 ($5,879)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2015-07-14 Purchase : show line 1 in the form +15,000 $0.16 $2,400 4,501,580 D
2015-07-14 Purchase : show line 2 in the form +5,000 $0.18 $900 4,506,580 D
2015-07-15 Purchase : show line 3 in the form +15,000 $0.17 $2,579 4,521,580 D
Open-market purchases · 35,000 sh · avg $0.17 · $5,879
Loading xslF345X03/primary_doc.xml…